Back

Spatial differentiation of proteome in cervical cancer tissues using Imaging Mass Spectrometry

Baliyan, A.; Mohapatra, I.; Paul, S.; Safiriyu, A. A.; Mondal, S. K.; Mishra, D.; Mandal, A. K.

2025-04-18 cancer biology
10.1101/2025.04.12.648495 bioRxiv
Show abstract

Cervical cancer, which is the fourth most common gynaecological cancer across the globe, has a poorly understood molecular pathogenesis and etiology. Current methods of diagnosis are based on cytology, histology and presence of Human Papillomavirus (HPV). Shortcomings of these methods lie with poor quality of smears which is very common in Papanicolaou (pap) smears, limited sensitivity in terms of early detection, dependence on presence of HPV, etc. Due to its high sensitivity and non-targeted approach, Matrix Assisted Laser Desorption Ionization based Imaging Mass Spectrometry (MALDI-IMS) might be advantageous to understand the pathogenesis, molecular mechanism, precise identification of surgical margins and identification of novel biomarkers. Since it can also identify proteins in the extracellular matrix, it is especially beneficial for the tissue types with sparse cells and excessive extracellular matrix. Although tissue proteome profiling for cervical cancer were reported, the heterogeneous distribution of proteins across cervical cancer tissues havent been explored. In this study, we employed a non-targeted MALDI-IMS based approach to profile the spatial distribution of proteins within cervical cancer tissues. We observed overexpression of Keratin 5 and Prelamin A/C in the region of cervical cancer tissues which were categorically labelled with cancerous morphology using histopathological examination. Both these proteins have been earlier associated with progression and aggressiveness of other cancers like breast and prostate cancers. However, no such reports are available for cervical cancer. Further studies are required on a large dataset to validate and quantitate these proteins as biomarkers for early diagnosis and prognosis of cervical cancer.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Journal of Proteomics
28 papers in training set
Top 0.1%
22.8%
2
Journal of Proteome Research
234 papers in training set
Top 0.2%
19.2%
3
PLOS ONE
5266 papers in training set
Top 20%
9.3%
50% of probability mass above
4
PROTEOMICS
43 papers in training set
Top 0.1%
8.2%
5
Clinical Proteomics
11 papers in training set
Top 0.1%
5.4%
6
Molecular & Cellular Proteomics
158 papers in training set
Top 0.5%
4.2%
7
Analytical Chemistry
218 papers in training set
Top 1%
2.2%
8
ACS Omega
105 papers in training set
Top 1%
2.2%
9
Scientific Reports
3612 papers in training set
Top 52%
1.8%
10
Analytical Biochemistry
26 papers in training set
Top 0.2%
1.8%
11
Cancers
213 papers in training set
Top 3%
1.8%
12
Journal of the American Society for Mass Spectrometry
37 papers in training set
Top 0.3%
1.5%
13
Oncotarget
18 papers in training set
Top 0.3%
1.1%
14
Molecules
39 papers in training set
Top 1%
1.0%
15
International Journal of Molecular Sciences
494 papers in training set
Top 13%
1.0%
16
Journal of Translational Medicine
57 papers in training set
Top 2%
0.9%
17
eLife
5828 papers in training set
Top 63%
0.9%
18
International Journal of Biological Macromolecules
76 papers in training set
Top 2%
0.9%
19
Neoplasia
23 papers in training set
Top 0.9%
0.6%
20
DNA Research
26 papers in training set
Top 0.5%
0.5%
21
Biochemistry and Biophysics Reports
30 papers in training set
Top 2%
0.5%
22
Cells
249 papers in training set
Top 9%
0.5%
23
Frontiers in Oncology
103 papers in training set
Top 4%
0.5%
24
Molecular Omics
23 papers in training set
Top 0.6%
0.5%